Abstract
Introduction/BackgroundThe TCGA molecular classification of endometrial cancer (EC) has proven prognostic impact for patients with intermediate-risk EC. The randomised PORTEC-3 trial investigated the benefit of combined adjuvant chemotherapy and radiotherapy...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have